The research unit at Remeo focuses on improving the care for patients with chronic or persistent critical illness.

These patients need intensive care treatment for long periods of time and may suffer from a wide array of diseases, requiring individualized, multidisciplinary care and rehabilitation during their recovery period. Our research goal is to improve the understanding of chronic/persistent critical illness with the aim to support recovery in the best possible way.

Eva Sundman, at Remeo and Karolinska Institutet, Stockholm, is head of the unit and may be contacted at

Follow us on Twitter @RemeoResearch.

Ongoing studies

Outcome of patients treated at a specialized multidisciplinary rehabilitation clinic following prolonged intensive care

This study is based on data from the Remeo quality registry and includes patients treated at Remeo 2015-2018. Success rates of weaning from mechanical ventilation and tracheostomy will be analyzed as well as discharge destinations, two-year survival rates after discharge, and more.

Specialized care and patient related outcome measures in persistent critical illness

This is a prospective study with ongoing patient inclusion. We aim to document patient and treatment characteristics as well as outcomes from the multidisciplinary rehabilitation using validated instruments for physical testing and patient reported outcome measures.

Prevalence and characteristics of dysphagia following prolonged intensive care and rehabilitation at Remeo

This study aims to describe and characterise dysphagia in patients who have experienced a prolonged period of intensive care using retrospective swallowing assessment data from patients routinely treated for dysphagia at Remeo.

Dysphagia scales: translation and evaluation of validity and reliability

Dysphagia scales commonly used internationally (valid and reliable in the English language) are translated into Swedish and validated for clinical and scientific use in Swedish healthcare and research.

Recent publications

Tracheostomy management by speech-language pathologists in Sweden

Sara Wiberg, Susanna Whitling & Liza Bergström

A Consensus Statement for the Management and Rehabilitation of Communication and Swallowing Function in the ICU: A Global Response to COVID-19

Amy Freeman-Sanderson, PhD, Elizabeth C. Ward, PhD, Anna Miles, PhD, Irene de Pedro Netto, PhD, Sallyanne Duncan, MSc, Yoko Inamoto, PhD, Jackie McRae, PhD, Natasha Pillay, MS, Stacey A. Skoretz, PhD, Margaret Walshe, PhD, Martin B. Brodsky, PhD, ScM, on behalf of the COVID-19 SLP Global Group

Prolonged elevation of plasma HMGB1 is associated with cognitive impairment in intensive care unit survivors

Emily Brück, Julie Lasselin, The HICUS study group, Ulf Andersson, Peter V. Sackey and Peder S. Olofsson.

Lack of clinically relevant correlation between subjective and objective cognitive function in ICU survivors: a prospective 12-month follow-up study

Emily Brück, Jacob W. Larsson, Julie Lasselin, Matteo Bottai, Tatja Hirvikoski, Eva Sundman, Michael Eberhardson, Peter Sackey and Peder S. Olofsson.

Specialized treatment of patients with persistent critical illness

Outcome of patients treated at the REMEO clinic 2015 – 2018 Author: Mathias Löfroth, medical student Karolinska Institutet Supervisor: Eva Sundman Remeo and Karolinska Institutet

Patient related outcome measures after specialized treatment of persistent critical illness – A pilot study on feasibility

Author: Sofia Bråse, medical student Uppsala University Supervisor: Eva Sundman Remeo and Karolinska Institutet